Form 4: CME Group Director Larry Gerdes Sells Shares in April 2025

Director Larry Gerdes sold a total of 4,000 shares of CME Group Class A common stock in late April 2025.

Summary

• On April 24, 2025, Larry Gerdes, a director of CME Group Inc., sold 1,000 shares of Class A common stock at a price of $263.1 per share.
• Later on the same day, he sold another 1,000 shares at a weighted average price of $265.1026, with individual prices ranging from $265.00 to $265.17.
• On April 25, 2025, Mr. Gerdes sold an additional 2,000 shares at a weighted average price of $266.1194, with individual prices ranging from $266.01 to $266.34.
• Following these transactions, Mr. Gerdes beneficially owns 36,651.15 shares of CME Group Class A common stock.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock sales by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider and provides transparency to the market regarding the trading activities of key personnel.

Stakeholder Impact

• The stock sale by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction relative to the director's holdings.

Key Dates

Keywords

CME Group, Larry Gerdes, stock sale, Form 4, director, Class A common stock, securities, ownership